statistiche ricercatore

statistiche per TERZOLO, Massimo

Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9978
EU - Europa 8317
AS - Asia 4306
SA - Sud America 492
OC - Oceania 334
AF - Africa 173
Continente sconosciuto - Info sul continente non disponibili 17
Totale 23617
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9485
IT - Italia 3582
CN - Cina 1925
DE - Germania 1384
GB - Regno Unito 565
JP - Giappone 508
FR - Francia 483
CA - Canada 397
AU - Australia 312
IN - India 312
KR - Corea 304
VN - Vietnam 298
ES - Italia 285
BR - Brasile 267
NL - Olanda 249
RU - Federazione Russa 249
PL - Polonia 246
TR - Turchia 193
CZ - Repubblica Ceca 151
GR - Grecia 148
RO - Romania 125
ID - Indonesia 99
CH - Svizzera 97
TW - Taiwan 94
SE - Svezia 90
ZA - Sudafrica 86
CL - Cile 84
MX - Messico 79
PT - Portogallo 79
HK - Hong Kong 78
UA - Ucraina 69
AR - Argentina 66
AT - Austria 64
TH - Thailandia 62
BE - Belgio 60
IE - Irlanda 51
MY - Malesia 51
CO - Colombia 48
SG - Singapore 46
PH - Filippine 44
IR - Iran 42
LT - Lituania 42
IL - Israele 41
DK - Danimarca 38
PK - Pakistan 36
SA - Arabia Saudita 34
HU - Ungheria 32
NO - Norvegia 32
RS - Serbia 31
BG - Bulgaria 29
IQ - Iraq 27
SI - Slovenia 27
NZ - Nuova Zelanda 22
DZ - Algeria 21
HR - Croazia 20
EG - Egitto 19
FI - Finlandia 19
JO - Giordania 16
AE - Emirati Arabi Uniti 15
LB - Libano 14
BY - Bielorussia 13
EU - Europa 12
EC - Ecuador 11
ET - Etiopia 11
SK - Slovacchia (Repubblica Slovacca) 11
BD - Bangladesh 10
TN - Tunisia 10
LV - Lettonia 9
QA - Qatar 9
BA - Bosnia-Erzegovina 7
MT - Malta 7
SY - Repubblica araba siriana 7
VE - Venezuela 7
KE - Kenya 6
MK - Macedonia 6
BO - Bolivia 5
LU - Lussemburgo 5
MD - Moldavia 5
NG - Nigeria 5
PA - Panama 5
CY - Cipro 4
GE - Georgia 4
GT - Guatemala 4
KW - Kuwait 4
MA - Marocco 4
AL - Albania 3
BH - Bahrain 3
BN - Brunei Darussalam 3
EE - Estonia 3
KH - Cambogia 3
LK - Sri Lanka 3
OM - Oman 3
PE - Perù 3
PS - Palestinian Territory 3
UG - Uganda 3
A1 - ???statistics.table.value.countryCode.A1??? 2
AM - Armenia 2
AP - ???statistics.table.value.countryCode.AP??? 2
BI - Burundi 2
CR - Costa Rica 2
Totale 23593
Salva come PNG Salva come JPEG
Città #
Fairfield 1119
Houston 1042
Woodbridge 799
Ann Arbor 613
Seattle 579
Buffalo 499
Ashburn 470
Torino 458
Cambridge 397
Santa Cruz 375
Beijing 370
Wilmington 339
Dong Ket 219
Hangzhou 206
Shanghai 199
University Park 145
Warsaw 143
Tokyo 137
Pisa 135
San Diego 134
Rome 124
Guangzhou 113
Milan 112
Wuhan 108
Chengdu 98
Nürnberg 92
Ottawa 91
Nanjing 87
Würzburg 72
Clearwater 71
Las Vegas 71
Mountain View 71
Rochester 68
Taipei 68
Toronto 66
Changsha 65
Seoul 64
Shenyang 64
Munich 62
Muizenberg 60
Brescia 59
Chicago 50
Leawood 50
New York 50
Melbourne 49
Paris 49
Jakarta 48
Central District 45
Athens 44
Phoenix 43
London 41
Zhengzhou 41
Bangalore 40
São Paulo 40
Lake Forest 39
Genova 38
Bethesda 36
Bologna 36
Santiago 36
Dallas 35
Polska 35
Florence 34
Ankara 33
Canberra 33
Napoli 33
Buenos Aires 31
Duncan 31
Montréal 31
Istanbul 29
Madrid 29
Mosman 29
Los Angeles 28
A Coruña 27
Bucharest 27
Gurgaon 27
Moscow 27
Padova 27
Seongnam 27
Riva 26
Philadelphia 25
Pittsburgh 25
Brisbane 24
Jinan 24
Rotterdam 24
Southend 24
Vienna 24
Barcelona 23
Mexico 23
Hanoi 22
Nanchang 22
Provo 22
New Delhi 21
Palermo 21
Tottori 21
Cleveland 20
San Francisco 20
Baltimore 19
Columbus 19
Memphis 19
Providence 19
Totale 11899
Salva come PNG Salva come JPEG
Nome #
Diagnosi e terapia del carcinoma corticosurrenalico, file 193080 1956
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors., file 509540 1211
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification., file 8486 1040
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study., file 148006 851
Combination Chemotherapy in Advanced Adrenocortical Carcinoma., file 16086 727
Adjuvant mitotane treatment for adrenocortical carcinoma, file 145181 587
Hypertension and Acromegaly, file 553939 577
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases., file 22069 545
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma, file 291691 539
Practical treatment using mitotane for adrenocortical carcinoma., file 24599 511
New perspectives for mitotane treatment of adrenocortical carcinoma, file 699833 499
AME position statement on adrenal incidentaloma., file 13049 474
Abiraterone and increased survival in metastatic prostate cancer., file 145168 458
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection., file 148093 452
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease, file 5328 449
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas, file 171782 418
Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE), file 202159 414
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients, file 582047 410
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior., file 11182 406
Merits and pitfalls of mifepristone in Cushing's syndrome, file 7793 404
Management of adjuvant mitotane therapy following resection of adrenal cancer., file 193171 386
Autonomous hypercortisolism: definition and clinical implications, file 502966 355
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer, file 193062 349
Management of adrenal cancer: a 2013 update., file 187524 345
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations, file 25288 338
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study., file 189466 337
Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas, file 255080 329
Adrenocortical Carcinoma with Hypercortisolism., file 469085 302
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates, file 19794 299
Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study., file 148832 265
Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas, file 170627 253
Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment., file 148838 245
Comparison of Two Mitotane Starting dose Regimens in Patients with Advanced Adrenocortical Carcinoma., file 148087 234
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study., file 223267 226
Acromegaly is associated with increased cancer risk: a survey in Italy, file 388163 221
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines., file 22070 218
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement., file 148114 215
Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study, file 560549 215
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma., file 468969 212
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options., file 473675 211
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer., file 11179 203
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma., file 452054 203
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases., file 13604 201
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors, file 582072 194
Novel mutation of PPOX gene in a patient with abdominal pain and syndrome of inappropriate antidiuresis., file 452046 181
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma., file 148076 175
MITOTANE LEVELS PREDICT THE OUTCOME OF PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION., file 21107 171
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function., file 148107 170
Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients, file 553946 165
Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency., file 193064 164
Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma, file 343164 161
Dual-Energy X-ray Absorptiometry Predictors of Vertebral Deformities in Beta-Thalassemia Major, file 416075 158
Screening of Cushing's Syndrome in Outpatients with Type 2 Diabetes: Results of a Prospective Multicentric Study in Italy., file 193071 156
Palbociclib inhibits proliferation of human adrenocortical tumor cells., file 389278 154
Predictors of morbidity and mortality in acromegaly: an Italian survey., file 16085 153
Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal nonosteoporotic women in the early postmenopausal period., file 190533 146
Insights on the natural history of adrenal incidentalomas, file 582079 143
Evaluation of midnight salivary cortisol as a predictor factor for common carotid arteries intima media thickness in patients with clinically inapparent adrenal adenomas, file 43231 138
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer., file 16251 122
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer, file 343170 122
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma, file 388162 122
May an adrenal incidentaloma change its nature?, file 703254 117
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors, file 468956 114
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma, file 452051 113
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study, file 492512 112
In vitro antitumor activity of progesterone in human adrenocortical carcinoma., file 502102 112
Surgical remission of Cushing's syndrome reduces cardiovascular risk., file 148823 111
CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma, file 25435 109
Intermittent everolimus administration for malignant insulinoma, file 25719 106
Thyroid and colorectal cancer screening in acromegaly patients: Should it be different from that in the general population?, file 699812 87
Mitotane: new facts for an old drug, file 531657 80
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†, file 699069 80
PREOPERATIVE TREATMENT WITH METYRAPONE IN PATIENTS WITH CUSHING'S SYNDROME DUE TO ADRENAL ADENOMA., file 448819 79
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma, file 699746 79
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane., file 237828 74
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study, file 620014 72
Recovery of adrenal insufficiency is frequent after adjuvant mitotane therapy in patients with adrenocortical carcinoma, file 623389 71
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment, file 551713 65
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma, file 620032 65
Acute Primary Adrenal Insufficiency after Hip Replacement in a Patient with Acute Intermittent Porphyria., file 442917 64
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study., file 592508 64
The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen., file 501916 60
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells, file 415988 59
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy, file 699684 56
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study, file 699025 55
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study, file 699036 55
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma, file 23454 54
Cytotoxic effect of trabectedin in human adrenocortical carcinoma cell lines and primary cells, file 619995 51
Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma, file 620030 48
Is Follow-up of Adrenal Incidentalomas Always Mandatory?, file 620034 45
Efficacy of the EDP-M scheme plus adjunctive surgery in the management of patients with advanced adrenocortical carcinoma: The brescia experience, file 617967 43
Patients With Lung Cancer and Coronavirus Disease 2019 Epidemic: An Experience From an Italian University Hospital, file 699013 41
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆, file 588049 39
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer, file 699073 35
Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: A systematic review and meta-Analysis, file 517118 34
Effects of germline CYP2W1*6 and CYP2B6*6 single nucleotide polymorphisms on mitotane treatment in adrenocortical carcinoma: A multicenter ENSAT study, file 623391 32
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization, file 26748 30
Differential expression profiles of cell-to-matrix-related molecules in adrenal cortical tumors: Diagnostic and prognostic implications, file 773153 21
Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies, file 853729 20
null, file 859221 20
Totale 24457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24759
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2016/2017247 0000 00 00 00114133
2017/20181887 12670125127 162138 172179 158215220195
2018/20193667 259250219223 211192 203309 313403618467
2019/20205072 409341347477 357342 397509 550482434427
2020/20216018 410516453342 450557 525575 467588544591
2021/20227049 670487427990 799461 756694 5644957060
Totale 24759
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie-Privacy
Logo CINECA  Copyright © 2022